Nurdiana Zainuddin
Research Subjects
Research Interests
Nurdiana Zainuddin has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Hidayah Karuniawati
Department of Pharmacology and Clinical Pharmacy, Universitas Muhammadiyah Surakarta, Surakarta, Indonesia
1 shared publication - Parameswari Nalliappan
Transfusion Medicine Specialist, Queen Elizabeth II Hospital, Malaysia
1 shared publication - Wan Ismahanisa Ismail
Faculty of Health Sciences, Universiti Teknologi MARA, Cawangan Pulau Pinang, Kampus Bertam, 13200 Kepala Batas, Pulau Pinang, Malaysia
1 shared publication
Latest Publications
- Open Access
- 31 October 2024
- Published by e-IPH Ltd. in Environment-Behaviour Proceedings Journal
- Vol. 9 (30) , 85-91
Knowledge, Attitude and Practice of Conventional Medicine Among Thalassaemia In Malaysia: Conceptual paper
Thalassaemia is chronic hereditary blood disorder. Medication has extended patients' lifespans, but research on their quality of life is scarce due to psychological impacts and medication adherence issues. The objective is to develop and validate a survey assessing the knowledge, attitude, and practice of Malaysian thalassaemia patients towards medication. We will use an exploratory mixed-methods approach with ethical approval from UiTM. Phase I involves semi-structured interviews with thalassaemia patients. Phase II focusses on creating and validating KAP instruments with expert panels and pilot testing. The tools will help medical professionals gather data to improve treatment compliance.
- 31 October 2024
- Published by e-IPH Ltd. in Environment-Behaviour Proceedings Journal
- Vol. 9 (30) , 85-91
Open AccessKnowledge, Attitude and Practice of Conventional Medicine Among Thalassaemia In Malaysia: Conceptual paper
Thalassaemia is chronic hereditary blood disorder. Medication has extended patients' lifespans, but research on their quality of life is scarce due to psychological impacts and medication adherence issues. The objective is to develop and validate a survey assessing the knowledge, attitude, and practice of Malaysian thalassaemia patients towards medication. We will use an exploratory mixed-methods approach with ethical approval from UiTM. Phase I involves semi-structured interviews with thalassaemia patients. Phase II focusses on creating and validating KAP instruments with expert panels and pilot testing. The tools will help medical professionals gather data to improve treatment compliance.